1
|
Ikeda R, Matsuoka Y, Inoue M, Ishikawa A, Akagi K, Kageyama Y. Treatment-related neuroendocrine prostate cancer with BRCA2 germline mutation treated with olaparib. IJU Case Rep 2024; 7:115-119. [PMID: 38440716 PMCID: PMC10909146 DOI: 10.1002/iju5.12679] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2023] [Accepted: 11/29/2023] [Indexed: 03/06/2024] Open
Abstract
Introduction The efficacy of olaparib for treatment-related neuroendocrine prostate cancer is unknown. Here, we report a case of treatment-related neuroendocrine prostate cancer with a BRCA2 mutation that was treated with olaparib with 1-year efficacy. Case presentation A 75-year-old man initially diagnosed with prostate adenocarcinoma developed treatment-related neuroendocrine prostate cancer after 10-year androgen deprivation therapy. Despite the initial temporary effects of etoposide and carboplatin, the patient experienced prostate bed tumor recurrence 1 year after chemotherapy cessation. FoundationOne® detected a BRCA2 gene mutation, and olaparib was initiated after repeating one chemotherapy course using the same chemotherapeutic agents. The patient received olaparib with sustained tumor regression for 1 year without severe side effects. Conclusion Olaparib may be the treatment of choice for treatment-related neuroendocrine prostate cancer in patients with BRCA mutations.
Collapse
Affiliation(s)
- Riko Ikeda
- Department of Urology Saitama Cancer Center Saitama Japan
| | - Yoh Matsuoka
- Department of Urology Saitama Cancer Center Saitama Japan
| | - Masaharu Inoue
- Department of Urology Saitama Cancer Center Saitama Japan
| | | | - Kiwamu Akagi
- Department of Molecular Diagnosis and Cancer Prevention Saitama Cancer Center Saitama Japan
| | - Yukio Kageyama
- Department of Urology Saitama Cancer Center Saitama Japan
| |
Collapse
|
2
|
Sekiguchi Y, Nishimura Y, Kanda H, Kawamura M, Kobayashi K, Mitani K, Kurashina R, Ikeda R, Inoue M, Matsuoka Y, Kageyama Y, Akaba Y, Kobayashi H. A Case of Immune Thrombocytopenia Occurring after Radiotherapy plus Atezolizumab Treatment for Bladder Cancer. Gan To Kagaku Ryoho 2023; 50:985-992. [PMID: 37800294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/07/2023]
Abstract
An 84-year-old female developed gross hematuria. She was diagnosed as urinary bladder carcinoma. She was initiated on concurrent atezolizumab plus radiation(a phase Ⅱ clinical trial)(jRCT2031180060). After 8 cycles of atezolizumab, complete response was confirmed. Maintenance atezolizumab treatment was started. Platelet(Plt)count decreased, there was no rechallenge with atezolizumab. Bone marrow examination revealed normal. Plt count recovered. Plt count decreased again. The serum levels of interleukin-6(IL-6)were elevated. She was diagnosed as having immune thrombocytopenia. She was started on treatment with prednisolone(PSL)at dose of 20 mg/day. Plt count was increased.
Collapse
|
3
|
Yamazaki H, Kobayashi T, Hiranai S, Sawahata M, Toida N, Sato F, Hinata J, Terakado M, Ishita K, Ikeda R, Shinya T, Yajima S, Kajiwara K. Evaluation of a newly developed low reflection dummy load for high power millimeter waves. Fusion Engineering and Design 2023. [DOI: 10.1016/j.fusengdes.2023.113684] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/03/2023]
|
4
|
Soma T, Fukuda S, Matsuyama Y, Ikeda R, Inoue M, Waseda Y, Tanaka H, Yoshida S, Yokoyama M, Matsuoka Y, Fujiwara T, Kageyama Y, Fujii Y. Peritoneal closure and the processus vaginalis transection method to prevent inguinal hernia after robot-assisted radical prostatectomy. Int J Urol 2023. [PMID: 36855807 DOI: 10.1111/iju.15170] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2022] [Accepted: 02/06/2023] [Indexed: 03/02/2023]
Abstract
OBJECTIVES Postoperative inguinal hernia (IH) is one of the most common complications of radical prostatectomy (RP) including robot-assisted RP (RARP). However, a procedure to prevent IH after RARP has not been established. We investigated the impact of processus vaginalis transection (PVT) and PVT with peritoneal closure on IH after RARP. METHODS A retrospective analysis was performed on data from patients who underwent RARP at two tertiary hospitals in Japan, where PVT with subsequent peritoneal closure was introduced after 2014. The incidence of IH for 2 years after RARP was compared among 79 patients without PVT or peritoneal closure, 232 patients with only PVT, and 325 patients with PVT and peritoneal closure. Multivariable Cox proportional hazard models that adjusted for hospital, age, history of abdominal operation, body mass index, operation time, and prostate weight were used. RESULTS Postoperative IH was observed in seven (8.9%) patients without PVT or peritoneal closure, 34 (15%) patients with only PVT, and nine (2.8%) patients with PVT and peritoneal closure. Compared with patients without PVT or peritoneal closure, the incidence of IH was not different in patients with only PVT (hazard ratio [HR] 0.89, 95% confidence interval [CI] 0.34, 2.38) and significantly lower in patients with PVT and peritoneal closure (HR 0.22, 95% CI 0.07, 0.70). CONCLUSION PVT with peritoneal closure may reduce the risk of postoperative IH after RARP. Future randomized controlled trials are required to confirm these findings.
Collapse
Affiliation(s)
- Takahiko Soma
- Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan
| | - Shohei Fukuda
- Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan
| | - Yusuke Matsuyama
- Department of Global Health Promotion, Tokyo Medical and Dental University, Tokyo, Japan
| | - Riko Ikeda
- Department of Urology, Saitama Cancer Center Hospital, Saitama, Japan
| | - Masaharu Inoue
- Department of Urology, Saitama Cancer Center Hospital, Saitama, Japan
| | - Yuma Waseda
- Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan
| | - Hajime Tanaka
- Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan
| | - Soichiro Yoshida
- Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan
| | - Minato Yokoyama
- Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan
| | - Yoh Matsuoka
- Department of Urology, Saitama Cancer Center Hospital, Saitama, Japan
| | - Takeo Fujiwara
- Department of Global Health Promotion, Tokyo Medical and Dental University, Tokyo, Japan
| | - Yukio Kageyama
- Department of Urology, Saitama Cancer Center Hospital, Saitama, Japan
| | - Yasuhisa Fujii
- Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan
| |
Collapse
|
5
|
Ikeda R, Matsuoka Y, Fukui N, Inoue M, Ishikawa A, Kageyama Y. Late recurrence of late-onset large cell calcifying Sertoli tumor successfully managed by early surgical intervention. Urol Case Rep 2022; 45:102227. [PMID: 36164376 PMCID: PMC9508428 DOI: 10.1016/j.eucr.2022.102227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2022] [Accepted: 09/16/2022] [Indexed: 10/28/2022] Open
|
6
|
Ikeda R, Ichihara Y, Yamada Y, Saito S, Nishinaka T, Shinkawa T, Niinami H. Optimization of Left Ventricle Size After VAD Implantation Prevents Incidence of Cerebral Infarction. J Heart Lung Transplant 2022. [DOI: 10.1016/j.healun.2022.01.1163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
7
|
Kobayashi T, Yamazaki H, Hiranai S, Sawahata M, Terakado M, Ishita K, Hinata J, Sato F, Wada K, Ikeda R, Shinya T, Yajima S, Kajiwara K, Takahashi K, Moriyama S. High power experiment and heat load evaluation of transmission line for the ECH/CD system in JT-60SA. Fusion Engineering and Design 2022. [DOI: 10.1016/j.fusengdes.2022.113009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
8
|
Yajima S, Kobayashi T, Kajiwara K, Ikeda R, Takahashi K. Development of a new analytic method for miter bend polarizer on ECW transmission line. Fusion Engineering and Design 2021. [DOI: 10.1016/j.fusengdes.2021.112487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
9
|
Yajima S, Kajiwara K, Isozaki M, Kobayashi N, Ikeda R, Kobayashi T, Shinya T, Yamazaki H, Takahashi K. Estimation of RF power absorption and stray distribution at plasma breakdown based on the design of ITER ECH&CD equatorial launcher. Fusion Engineering and Design 2021. [DOI: 10.1016/j.fusengdes.2021.112470] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
10
|
Ikeda R, Ichihara Y, Yamada Y, Saito S, Nishinaka T, Niinami H. Reversal and Resumption of Anti-Thrombotic Therapy in VAD-Related Hemorrhage. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.1102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
11
|
Yokota T, Yoshikawa N, Arimori K, Ikeda R. Retrospective analysis of risk factors for liposomal amphotericin B-associated nephrotoxicity. Pharmazie 2020; 75:599-601. [PMID: 33239137 DOI: 10.1691/ph.2020.0731] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
In this study, we examined patients who received liposomal amphotericin B (L-AMB) to determine the risk factors associated with nephrotoxicity before and during L-AMB treatment. In this retrospective, single-center, observational cohort study, we examined 37 patients who received L-AMB treatment between April 2018 and December 2019. Nephrotoxicity was observed in 11 (29.7%) patients. We focused on the baseline albumin level and body surface area (BSA) before L-AMB treatment. Univariate analysis showed that the BSA and baseline albumin levels in patients with nephrotoxicity were significantly higher than those in patients without nephrotoxicity. Moreover, univariate analysis showed that albumin supplementation was significantly associated with the frequency of nephrotoxicity during L-AMB treatment. Multiple logistic regression analysis revealed the following independent risk factors for nephrotoxicity before or during L-AMB treatment: baseline albumin level (odds ratio [OR] = 16.000; 95% CI 1.480-172.000; P = 0.022) and albumin supplementation (OR = 40.800; 95% CI 2.210-753.000; P = 0.013). In conclusion, we identified baseline albumin level and albumin supplementation as novel risk factors for L-AMB-induced nephrotoxicity.
Collapse
Affiliation(s)
- T Yokota
- Department of Pharmacy, University of Miyazaki Hospital, Miyazaki, Japan
| | - N Yoshikawa
- Department of Pharmacy, University of Miyazaki Hospital, Miyazaki, Japan;,
| | - K Arimori
- Department of Pharmacy, University of Miyazaki Hospital, Miyazaki, Japan
| | - R Ikeda
- Department of Pharmacy, University of Miyazaki Hospital, Miyazaki, Japan
| |
Collapse
|
12
|
Yamamoto T, Ikeda R, Yamada D, Saitoh A, Koshiji K. Development of a high-hydrous gel phantom for human body communication based on electrical anisotropy. Annu Int Conf IEEE Eng Med Biol Soc 2020; 2019:4028-4031. [PMID: 31946755 DOI: 10.1109/embc.2019.8857862] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
In this study, we investigated a highly hydrated gel phantom with electrical anisotropy that can be used at 18.375 MHz to 23.625 MHz. This is one of the frequency bands used for human body communication. To achieve the communication, the electrical characteristics of the quadriceps femoris muscle of the rat were measured immediately after sacrifice. These were used to obtain an indicator of electrical characteristics to be satisfied by the phantom. Electrical anisotropy was realized by adding carbon fiber to the phantom and controlling its direction. We were able to develop a high hydrated gel phantom for human body communication with a maximum error of 8.1% assuming its use at 18.735 MHz to 23.625 MHz.
Collapse
|
13
|
Bin W, Bruschi A, Fanale F, Francesca M, Lucca F, Albajar F, Alberti S, Carannante G, Cavinato M, Chelis I, Dell'Era F, Fasel D, Gantenbein G, Goodman T, Granucci G, Hogge JP, Ikeda R, Ioannidis Z, Legrand F, Mellera V, Minelli D, Nardone A, Pagonakis I, Rispoli N, Rzesnicki T, Sanchez F, Spinicchia N, Takahashi K, Tigelis I, Viganò F. Tests and developments of a long-pulse high-power 170 GHz absorbing matched load. Fusion Engineering and Design 2019. [DOI: 10.1016/j.fusengdes.2018.11.019] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
14
|
Affiliation(s)
- Y Suyama
- Division of Rheumatology, JR Tokyo General Hospital, 2-1-3 Yoyogi Shibuya-Ku, Tokyo 151-8528, Japan and Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University, 9-1 Akashi-cho Chuo-Ku, Tokyo 104-8560, Japan
| | - R Ikeda
- Department of Neurosurgery, JR Tokyo General Hospital, 2-1-3 Yoyogi Shibuya-Ku, Tokyo, 151-8528, Japan
| | - S Tanaka
- Department of Pathology, JR Tokyo General Hospital, 2-1-3 Yoyogi Shibuya-Ku, Tokyo, 151-8528, Japan
| | - K Hagiwara
- Division of Rheumatology, JR Tokyo General Hospital, 2-1-3 Yoyogi Shibuya-Ku, Tokyo, 151-8528, Japan
| |
Collapse
|
15
|
Oda Y, Ikeda R, Takahashi K, Kajiwara K, Kobayashi T, Sakamoto K, Moriyama S, Darbos C, Henderson M. Recent activities of ITER gyrotron development in QST. EPJ Web Conf 2017. [DOI: 10.1051/epjconf/201714901002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
16
|
Yoshimura Y, Kubo S, Shimozuma T, Igami H, Takahashi H, Kobayashi S, Ito S, Mizuno Y, Takita Y, Nakamura Y, Ohkubo K, Ikeda R, Ida K, Yoshinuma M, Sakakibara S, Mutoh T, Nagasaki K, Idei H, Notake T. Progress Toward Steady-State Operation in LHD Using Electron Cyclotron Waves. Fusion Science and Technology 2017. [DOI: 10.13182/fst58-551] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Y. Yoshimura
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - S. Kubo
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - T. Shimozuma
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - H. Igami
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - H. Takahashi
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - S. Kobayashi
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - S. Ito
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - Y. Mizuno
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - Y. Takita
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - Y. Nakamura
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Ohkubo
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - R. Ikeda
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Ida
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - M. Yoshinuma
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - S. Sakakibara
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - T. Mutoh
- National Institute for Fusion Science, Toki 509-5292, Japan
| | - K. Nagasaki
- Institute of Advanced Energy, Kyoto University, Uji 611-0011, Japan
| | - H. Idei
- Research Institute for Applied Mechanics, Kyushu University, Kasuga 816-8580, Japan
| | - T. Notake
- Tera-Photonics Laboratory, RIKEN, Sendai 980-0845, Japan
| | | |
Collapse
|
17
|
Kuroda Y, Ikeda R, Yamazaki T, Ito K, Uda K, Wakabayashi K, Watanabe T. Activation of human bitter taste receptors by polymethoxylated flavonoids. Biosci Biotechnol Biochem 2016; 80:2014-7. [PMID: 27379685 DOI: 10.1080/09168451.2016.1184558] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Tangeretin and nobiletin are polymethoxylated flavonoids in citrus peel. Both tangeretin and nobiletin are bitter; however, their bitterness has not been evaluated using human bitter taste receptors (hTAS2Rs). We screened 25 kinds of hTAS2Rs and found that hTAS2R14 and hTAS2R46 received both compounds.
Collapse
Affiliation(s)
- Yuki Kuroda
- a Graduate School of Integrated Pharmaceutical and Nutritional Sciences , University of Shizuoka , Shizuoka , Japan
| | - Riko Ikeda
- a Graduate School of Integrated Pharmaceutical and Nutritional Sciences , University of Shizuoka , Shizuoka , Japan
| | - Toyomi Yamazaki
- a Graduate School of Integrated Pharmaceutical and Nutritional Sciences , University of Shizuoka , Shizuoka , Japan
| | - Keisuke Ito
- a Graduate School of Integrated Pharmaceutical and Nutritional Sciences , University of Shizuoka , Shizuoka , Japan
| | - Kazunari Uda
- a Graduate School of Integrated Pharmaceutical and Nutritional Sciences , University of Shizuoka , Shizuoka , Japan
| | - Keiji Wakabayashi
- a Graduate School of Integrated Pharmaceutical and Nutritional Sciences , University of Shizuoka , Shizuoka , Japan
| | - Tatsuo Watanabe
- a Graduate School of Integrated Pharmaceutical and Nutritional Sciences , University of Shizuoka , Shizuoka , Japan
| |
Collapse
|
18
|
Shimizu NS, Handa A, Shimizu NG, Ikeda R, Uchiyama T, Achiwa K, Hoshino H. Inhibition of Infection of T-Cells with Human Immunodeficiency Virus Type 1 by Dideoxynucleosides Conjugated with Oligopeptides. ACTA ACUST UNITED AC 2016. [DOI: 10.1177/095632029500600103] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
We conjugated nucleoside derivatives that have anti-HIV-1 activities with oligopeptides that should bind to the gp120 of the HIV-1 virion, and examined their anti-HIV-1 activities. These derivates included 3′-azido-2′,3′-dideoxythymidine (AZT), 2′,3′-dideoxyuridine (ddU), 2′,3′-dideoxycytidine (ddC), 2′,3′-dideoxyinosine (ddI) and 2′,3′-dideoxyadenine (ddA). Dipeptides consisting of N-carbomethoxy-carbonyl-prolyl-phenylalanylbenzyl ester (CPF) and oligopeptides derived from the complementarity-determining region 2 (CDR2) of domain 1 of CD4 were synthesized. The N-terminals of these peptides were conjugated with the 5′OH of AZT, ddU, ddC, ddl or ddA through carbonyl moieties. CPF conjugated with AZT, ddC, ddl or ddA through two-carbonyl moieties exhibited powerful anti-HIV-1 activity, which was similar to that of the respective nucleosides when compared at the same molar concentration. No complex compound connected by a one-carbonyl moiety had anti-HIV-1 activity, whereas a tetrapeptide or octapeptide of the CDR2 region combined with AZT did have such activity. The toxicity of these CPF-containing compounds to human peripheral blood lymphocytes was slightly weaker than the toxicities of the corresponding nucleosides lacking CPF. Antiviral nucleosides containing oligopeptides may be used as lead compounds in an effort to isolate more effective and less cytotoxic anti-HIV-1 agents.
Collapse
Affiliation(s)
- N. S. Shimizu
- Department of Hygiene and Virology, Gunma University School of Medicine, Showa-machi, Maebashi, Gunma 371, Japan
| | - A. Handa
- Department of Hygiene and Virology, Gunma University School of Medicine, Showa-machi, Maebashi, Gunma 371, Japan
| | - N. G. Shimizu
- Department of Hygiene and Virology, Gunma University School of Medicine, Showa-machi, Maebashi, Gunma 371, Japan
| | - R. Ikeda
- Department of Hygiene and Virology, Gunma University School of Medicine, Showa-machi, Maebashi, Gunma 371, Japan
- Laboratory of Infectious Diseases, Nippon Kayaku Co., Ltd, Iwahana-machi, Takasaki, Gunma 370-12, Japan
| | - T. Uchiyama
- School of Pharmaceutical Sciences, University of Shizuoka, Yada 395, Shizuoka 422, Japan
| | - K. Achiwa
- School of Pharmaceutical Sciences, University of Shizuoka, Yada 395, Shizuoka 422, Japan
| | - H. Hoshino
- Department of Hygiene and Virology, Gunma University School of Medicine, Showa-machi, Maebashi, Gunma 371, Japan
| |
Collapse
|
19
|
Takahashi K, Abe G, Kajiwara K, Oda Y, Isozaki M, Ikeda R, Sakamoto K, Omori T, Henderson M. Design modification of ITER equatorial EC launcher for electron cyclotron heating and current drive optimization. Fusion Engineering and Design 2015. [DOI: 10.1016/j.fusengdes.2015.04.058] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
20
|
Matsui K, Mori A, Ikeda R. Langerhans cell-like dendritic cells stimulated with an adjuvant direct the development of Th1 and Th2 cells in vivo. Clin Exp Immunol 2015; 182:101-7. [PMID: 26084192 DOI: 10.1111/cei.12671] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/15/2015] [Indexed: 12/14/2022] Open
Abstract
It is well known that Langerhans cells (LCs) work as the primary orchestrators in the polarization of immune responses towards a T helper type 1 (Th1) or Th2 milieu. In this study, we attempted to generate LCs from murine bone marrow cells and elicit a Th1- or Th2-prone immune response through the LCs after stimulation with Th1 or Th2 adjuvant. LCs were generated from murine bone marrow cells using granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-4 and transforming growth factor (TGF)-β, and were obtained as I-A(d) positive cells. Mice were primed with Th1/Th2 adjuvant- and ovalbumin (OVA)-pulsed LCs and then given a booster injection of OVA 2 days later via the hind footpad. Five days after the OVA injection, the cytokine response in the draining popliteal lymph nodes was investigated by reverse transcription-polymerase chain reaction (RT-PCR) flow cytometry and enzyme-linked immunosorbent assay (ELISA). The generated LCs expressed typical LC surface markers, E-cadherin and Langerin, and were classified accordingly as LC-like dendritic cells (LDCs). Administration of Th1 adjuvant, cytosine-phosphate-guanosine (CpG)-DNA- and OVA-pulsed LDCs into the hind footpads of mice induced a Th1-prone immune response, as represented by up-regulation of IFN-γ production and down-regulation of IL-4 production in the lymph node cells. Conversely, Th2 adjuvant, histamine-pulsed LDCs induced a Th2-prone immune response, as represented by up-regulation of IL-4 production and down-regulation of IFN-γ production. These results suggest that LDCs may be used as a substitute for LCs and have the ability to induce the development of Th1 and Th2 cells in vivo. Our experimental system would therefore be useful for screening of inhibitors of Th1/Th2 differentiation in order to control allergic disease.
Collapse
Affiliation(s)
- K Matsui
- Department of Microbial Science and Host Defense, Meiji Pharmaceutical University, Tokyo, Japan
| | - A Mori
- Department of Microbial Science and Host Defense, Meiji Pharmaceutical University, Tokyo, Japan
| | - R Ikeda
- Department of Microbial Science and Host Defense, Meiji Pharmaceutical University, Tokyo, Japan
| |
Collapse
|
21
|
Yamazaki T, Sagisaka M, Ikeda R, Nakamura T, Matsuda N, Ishii T, Nakayama T, Watanabe T. The human bitter taste receptor hTAS2R39 is the primary receptor for the bitterness of theaflavins. Biosci Biotechnol Biochem 2014; 78:1753-6. [DOI: 10.1080/09168451.2014.930326] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Abstract
We purified several hundred mgs of four major theaflavins (theaflavin, theaflavin-3-O-gallate, theaflavin-3′-O-gallate, and theaflavin-3,3′-O-digallate). Among the 25 hTAS2Rs expressed in HEK293T cells, hTAS2R39 and hTAS2R14 were activated by theaflavins. Both hTAS2R39 and hTAS2R14 responded to theaflavin-3′-O-gallate. In addition, hTAS2R39 was activated by theaflavin and theaflavin-3,3′-O-gallate, but not by theaflavin-3-O-gallate. In contrast, hTAS2R14 responded to theaflavin-3-O-gallate.
Collapse
Affiliation(s)
- Toyomi Yamazaki
- Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Shizuoka, Japan
| | - Miki Sagisaka
- Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Shizuoka, Japan
| | - Riko Ikeda
- Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Shizuoka, Japan
| | - Toshiyuki Nakamura
- Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Shizuoka, Japan
| | - Noriko Matsuda
- Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Shizuoka, Japan
| | - Takeshi Ishii
- Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Shizuoka, Japan
| | - Tsutomu Nakayama
- Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Shizuoka, Japan
| | - Tatsuo Watanabe
- Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Shizuoka, Japan
| |
Collapse
|
22
|
Tamura A, Maruyama Y, Ishitobi Y, Kawano A, Ando T, Ikeda R, Inoue A, Imanaga J, Okamoto S, Kanehisa M, Ninomiya T, Tanaka Y, Tsuru J, Akiyoshi J. Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in patients with the generalized type of social anxiety disorder. Pharmacopsychiatry 2013; 46:225-60. [PMID: 23975855 DOI: 10.1055/s-0033-1353157] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
INTRODUCTION Social anxiety disorder is believed to be a stress-induced disease. Although it can be inferred from the symptoms during attacks that there exists some abnormality of autonomic nervous system in any of the stress systems in social anxiety disorder, little evidence has been reported. This study focused on comparing the reactivity of 2 stress systems, the autonomic nervous system (ANS) and the hypothalamic-pituitary-adrenal (HPA) axis in patients with social anxiety disorder. METHODS 32 patients with the generalized type of social anxiety disorder were compared with 80 age- and gender-matched controls. We collected saliva samples from patients and controls before and after electrical stimulation to measure the concentrations of salivary alpha-amylase (sAA) and salivary cortisol. Profile of Mood State (POMS) and State-Trait Anxiety Inventory (STAI) scores and Heart Rate Variability (HRV) were also determined following stimulation. RESULTS SAA in patients displayed a significantly higher level at baseline and a significantly larger response to electrical stimulation as compared to controls, whereas no group differences were seen in any HRV. Neither within-subject nor group differences were seen in salivary cortisol levels. CONCLUSIONS These results suggest that SAD patients displayed enhanced ANS (but not HPA axis) activity vs. healthy controls.
Collapse
Affiliation(s)
- A Tamura
- Department of Neuropsychiatry, Oita University Faculty of Medicine, Hasama-Machi, Oita, Japan
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Hamada A, Akiyoshi R, Ishii J, Hamada N, Miyazaki C, Hamada T, Ohwaki Y, Ikeda R, Wada M, Nakashima K. Influence of calcium channel blockers in patients with gastrointestinal disease in Japanese community pharmacies. J Clin Pharm Ther 2012; 37:74-7. [DOI: 10.1111/j.1365-2710.2011.01253.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
24
|
Ikeda R, Aiyama S, Redman RS. Exogenous thyroid hormone affects myoepithelium and proliferation in the developing rat parotid gland. Biotech Histochem 2010; 84:267-74. [PMID: 19468923 DOI: 10.3109/10520290902984258] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
In the mature rat parotid gland, myoepithelial cells (MEC) invest intercalated ducts, but not acini. During postnatal development, however, these cells differentiate around both intercalated ducts and acini, then translocate to only intercalated ducts during weaning. Previously, we found that thyroxine (T(4)) accelerates translocation of cells with small secretory granules from acini into intercalated ducts and the number of apoptotic cells increased tremendously with high doses. We present here additional analysis of the effects of T(4) on developing rat parotid gland, namely, the distribution of MEC and the proliferation of parenchymal cells. Beginning at age four days, pups were given daily subcutaneous injections of low, medium, and high doses of T(4) or vehicle or no injection. At ages 4, 7, 10, and 15 days, glands were excised and processed for light microscopy. Sections were double-immunostained with antibodies against proliferating cell nuclear antigen (PCNA) and actin, and counterstained with hematoxylin. Proliferative activity was assessed via PCNA histochemistry and MEC were identified using actin histochemistry. MEC in the T(4) groups invested mostly acini at 15 days in vehicle/normal glands and mostly intercalated ducts after 10 days in the T(4) groups. The proliferative activity of acinar cells and MEC in vehicle/normal glands declined progressively with age and T(4) increased the rate of this decline in the MEC in a dose-dependent manner. We conclude that T(4) accelerates the translocation of MEC from acini to intercalated ducts and that an important mechanism is the more rapid decline in the proliferative activity of MEC than in acinar cells in the T(4) groups. Some of the decline in the proliferative activity of all cells in the high and medium dose T(4) groups after seven days may have been due to dose-related thyroxine toxicity.
Collapse
Affiliation(s)
- R Ikeda
- Department of Dental Hygiene, The Nippon Dental University College at Tokyo, Tokyo, Japan.
| | | | | |
Collapse
|
25
|
Takemoto H, Murata K, Tomita N, Fukunaga M, Watanabe M, Ohue M, Ikeda R, Tanimoto K, Hiyama K, Nishiyama M. Pharmacogenomic analysis for prediction of individual response to mFOLFOX6 in colorectal cancer. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e13500] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
26
|
Chin K, Kato K, Yoshikawa T, Yamaguchi K, Esaki T, Tsuji Y, Sakai K, Kimura M, Ikeda R, Matsumura Y. Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle as second-line treatment for advanced or recurrent gastric cancer. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.4041] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
27
|
Ikeda R, Yoshida K, Satou Y, Takahashi M, Une Y, Yamamoto W, Tanimoto K, Hiyama K, Sasaki Y, Nishiyama M. Randomized phase II/III study of docetaxel/S-1 (DS-1) versus CDDP/5FU (FUP) in advanced or recurrent gastric cancer: Updated phase II results. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.4595] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
4595 Background: Our previous single arm phase II trial demonstrated that the combination of DS-1 was one of the most powerful candidates to become a standard regimen for metastatic gastric cancer (K. Yoshida, et al: Clin Cancer Res 2006). This trial evaluated DS-1 and FUP in advanced or recurrent gastric cancer, and the primary objective of the phase II part was to evaluate activity and safety of the 2 regimens. Methods: Patients with advanced or recurrent gastric cancer, who had not received any chemotherapy except one regimen (not including taxanes), were eligible for this trial. Patients were randomized to either: DS-1, intravenous administration of 40 mg/m2 docetaxel on Day1 and oral administration of 80–120 mg/m2/day S-1 on Days 1 to 14 every 3 weeks, or FUP, intravenous continuous administration of 800 mg/m2/day 5-FU on Day 1 to 5 and intravenous administration of 80 mg/m2/day CDDP on Day 2 every 4 weeks. Results: Between June 2005 and August 2008, forty-nine of 54 patients (ECOG PS 0–2) were randomized to DS-1 (n=24) or FUP (n=25). Response rates (CR+PR) assessed by RECIST were 88.3% (CI;62.6–95.3) vs 52.0% (CI; 31.3–72.2, P=0.032), median times to treatment failure (TTF) were 122 days (CI; 75.2–168.8) vs 85 days (CI;67.9–102.1, P=0.003), median progression free survivals (PFS) were 198 days (CI;117.8–278.4) vs 105 days (CI;90.3–119.7, P=0.066). Median overall survival times (MSTs) were 369 days (CI; 359.6–378.4) vs 371 days (CI; 297.2- 444.8, P=0.281), but as of today, 14 pts (8 in DS-1 and 6 in FUP) are still alive. Grade 3/4 adverse events assessed by CTCAE v3.0 occurring in ≥20% patients, were neutropenia (58.3% vs 28.0%), nausea (4.2% vs 20.0%), leucopenia (33.0% vs 4.0%), fatigue (0% vs 20.0%) and anorexia (8.3% vs 32.0%). All treatment-related adverse events were resolved and no toxic death was reported. Conclusions: DS-1 significantly improved the RR and TTF in advanced or recurrent gastric cancer patients. To clarify the survival benefit, a phase III continuation of the study is in preparation. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- R. Ikeda
- Development Organization for Frontier Med Therap., Hiroshima, Japan; Gifu University, Graduate School of Medicine, Gifu, Japan; Kawakita General Hospital, Tokyo, Japan; Asahikawa-Kosei General Hospital, Asahikawa, Japan; Nishi Sapporo Natl Hosp., Sapporo, Japan; Senju Central Clinic, Tokyo, Japan; Hiroshima University, R.I.R.B.M., Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - K. Yoshida
- Development Organization for Frontier Med Therap., Hiroshima, Japan; Gifu University, Graduate School of Medicine, Gifu, Japan; Kawakita General Hospital, Tokyo, Japan; Asahikawa-Kosei General Hospital, Asahikawa, Japan; Nishi Sapporo Natl Hosp., Sapporo, Japan; Senju Central Clinic, Tokyo, Japan; Hiroshima University, R.I.R.B.M., Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - Y. Satou
- Development Organization for Frontier Med Therap., Hiroshima, Japan; Gifu University, Graduate School of Medicine, Gifu, Japan; Kawakita General Hospital, Tokyo, Japan; Asahikawa-Kosei General Hospital, Asahikawa, Japan; Nishi Sapporo Natl Hosp., Sapporo, Japan; Senju Central Clinic, Tokyo, Japan; Hiroshima University, R.I.R.B.M., Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - M. Takahashi
- Development Organization for Frontier Med Therap., Hiroshima, Japan; Gifu University, Graduate School of Medicine, Gifu, Japan; Kawakita General Hospital, Tokyo, Japan; Asahikawa-Kosei General Hospital, Asahikawa, Japan; Nishi Sapporo Natl Hosp., Sapporo, Japan; Senju Central Clinic, Tokyo, Japan; Hiroshima University, R.I.R.B.M., Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - Y. Une
- Development Organization for Frontier Med Therap., Hiroshima, Japan; Gifu University, Graduate School of Medicine, Gifu, Japan; Kawakita General Hospital, Tokyo, Japan; Asahikawa-Kosei General Hospital, Asahikawa, Japan; Nishi Sapporo Natl Hosp., Sapporo, Japan; Senju Central Clinic, Tokyo, Japan; Hiroshima University, R.I.R.B.M., Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - W. Yamamoto
- Development Organization for Frontier Med Therap., Hiroshima, Japan; Gifu University, Graduate School of Medicine, Gifu, Japan; Kawakita General Hospital, Tokyo, Japan; Asahikawa-Kosei General Hospital, Asahikawa, Japan; Nishi Sapporo Natl Hosp., Sapporo, Japan; Senju Central Clinic, Tokyo, Japan; Hiroshima University, R.I.R.B.M., Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - K. Tanimoto
- Development Organization for Frontier Med Therap., Hiroshima, Japan; Gifu University, Graduate School of Medicine, Gifu, Japan; Kawakita General Hospital, Tokyo, Japan; Asahikawa-Kosei General Hospital, Asahikawa, Japan; Nishi Sapporo Natl Hosp., Sapporo, Japan; Senju Central Clinic, Tokyo, Japan; Hiroshima University, R.I.R.B.M., Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - K. Hiyama
- Development Organization for Frontier Med Therap., Hiroshima, Japan; Gifu University, Graduate School of Medicine, Gifu, Japan; Kawakita General Hospital, Tokyo, Japan; Asahikawa-Kosei General Hospital, Asahikawa, Japan; Nishi Sapporo Natl Hosp., Sapporo, Japan; Senju Central Clinic, Tokyo, Japan; Hiroshima University, R.I.R.B.M., Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - Y. Sasaki
- Development Organization for Frontier Med Therap., Hiroshima, Japan; Gifu University, Graduate School of Medicine, Gifu, Japan; Kawakita General Hospital, Tokyo, Japan; Asahikawa-Kosei General Hospital, Asahikawa, Japan; Nishi Sapporo Natl Hosp., Sapporo, Japan; Senju Central Clinic, Tokyo, Japan; Hiroshima University, R.I.R.B.M., Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| | - M. Nishiyama
- Development Organization for Frontier Med Therap., Hiroshima, Japan; Gifu University, Graduate School of Medicine, Gifu, Japan; Kawakita General Hospital, Tokyo, Japan; Asahikawa-Kosei General Hospital, Asahikawa, Japan; Nishi Sapporo Natl Hosp., Sapporo, Japan; Senju Central Clinic, Tokyo, Japan; Hiroshima University, R.I.R.B.M., Hiroshima, Japan; Saitama Medical University International Medical Center, Hidaka, Saitama, Japan
| |
Collapse
|
28
|
Ikeda R, Aiyama S, Redman RS. Exogenous thyroid hormone affects myoepithelium and proliferation in the developing rat parotid gland. Biotech Histochem 2009. [DOI: 10.1080/10520290902984258] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
29
|
Mizoguchi K, Ikeda R, Shoji H, Tanaka Y, Maruyama W, Tabira T. Aging attenuates glucocorticoid negative feedback in rat brain. Neuroscience 2008; 159:259-70. [PMID: 19141312 DOI: 10.1016/j.neuroscience.2008.12.020] [Citation(s) in RCA: 79] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2008] [Revised: 12/09/2008] [Accepted: 12/12/2008] [Indexed: 11/16/2022]
Abstract
Aging is thought to be a risk factor to develop vulnerability of the neuroendocrine system, including the hypothalamic-pituitary-adrenal (HPA) axis, and dysregulation of this axis characterized by dexamethasone (DEX)-mediated negative feedback resistance is sometimes observed in elderly humans and animals. However, the influence of aging on the feedback system including an involvement of the brain is not fully understood. In the present study, we examined the suppressive effects of DEX by the systemic injection or the intracranial infusion into the prefrontal cortex (PFC), hippocampus, and hypothalamus on circulating corticosterone levels, and compared between young (3-month-old) and aged (24-month-old) rats. Moreover, we examined expression levels of glucocorticoid receptors (GRs) and their translocation from the cytoplasm to the nucleus using immunohistochemical and Western immunoblot techniques in the pituitary in addition to three brain regions. When DEX was injected systemically, the suppressive response was significantly enhanced in aged rats, compared with young rats. When DEX was infused into three brain regions, the suppressive response to DEX was abolished in aged rats. The immunohistochemical analysis revealed that the number of GR positive cells in the PFC, hippocampus, and hypothalamus was decreased, but that in the pituitary was increased, in aged rats, compared with young rats. The Western immunoblot analysis confirmed these results. Thus, basal expression levels of GRs in three brain regions were decreased, but those in the pituitary were increased, in aged rats. After the injection or infusion of DEX, the translocation of GRs in three brain regions was reduced, but that in the pituitary was enhanced, in aged rats. These results suggest that aging in rats enhances the feedback ability at the systemic level, which mainly involves the pituitary, but it attenuates the ability in the brain. These mechanisms may underlie the vulnerable neuroendocrine systems associated with aging.
Collapse
Affiliation(s)
- K Mizoguchi
- Section of Oriental Medicine, Department of Geriatric Medicine, National Institute for Longevity Sciences, National Center for Geriatrics and Gerontology, 36-3 Gengo, Morioka, Obu, Aichi 474-8522, Japan.
| | | | | | | | | | | |
Collapse
|
30
|
Tanei H, Nakamura N, Ogi H, Hirao M, Ikeda R. Unusual elastic behavior of nanocrystalline diamond thin films. Phys Rev Lett 2008; 100:016804. [PMID: 18232804 DOI: 10.1103/physrevlett.100.016804] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/13/2007] [Indexed: 05/25/2023]
Abstract
This Letter studies the relationship between the elastic constants and the microstructure of nanocrystalline diamond thin films deposited by the chemical vapor deposition method doping various concentration of N2 gas. The elastic constants were measured by resonant ultrasound spectroscopy and picosecond laser ultrasounds. The increase of N2 gas decreases the diagonal elastic constants, but increases the off-diagonal elastic constants. The micromechanics calculation can explain this unusual elastic behavior, and it predicts thin graphitic phases at grain boundaries.
Collapse
Affiliation(s)
- H Tanei
- Graduate School of Engineering Science, Osaka University, Toyonaka, Osaka 560-8531, Japan
| | | | | | | | | |
Collapse
|
31
|
Ikeda R, Yoshida K, Takagane A, Tsuburaya A, Kobayashi O, Sunouchi H, Matsukawa M, Tanimoto K, Hiyama K, Nishiyama M. Pharmacogenomic (PG) analysis for prediction of individual response to paclitaxel in 5-FU-refractory metastatic gastric cancer: Prediction formula of tumor response using novel marker genes and genotypes associated with the toxicity. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.2538] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
2538 Background: Taxanes offer hope for improving outcomes of metastatic gastric cancer patients including 5-FU failure cases, but the response remarkably varies among patients. We conducted this prospective PG study for paclitaxel monotherapy to develop a prediction formula of efficacy and to identify potent genetic markers of toxicity. Methods: Paclitaxel was intravenously given on Days 1, 8, and 15, every 4 weeks in 5-FU failure metastatic gastric cancer patients with typical eligibility criteria. Tumor and blood samples were collected before the initial paclitaxel administration for PG. PK analysis was done on day 1 of cycle 1. Tumor response and toxicity were evaluated by RECIST and CTCAE, respectively. Results: Forty-nine pts were enrolled, and up to date, 48 and 44 pts have been determined for worst toxicity and best tumor response, respectively. Observed response rate was 27.3% (12/44), and common grade 3/4 toxicities were neutropenia (31.3%) and leucopenia (20.8%). PG analysis demonstrated that CYP2C8*1C (w/v=27, v/v=5) and CYP2C8 -411T>C (w/v=24, v/v=10) were weakly associated with grade 3/4 leucopenia (p=0.087 and 0.092), and CYP2C8 IVS7+49T> A (w/v=9, v/v=6) might correlate with grade 3/4 anemia (p=0.039), although none of them correlated with any PK parameter. We identified 4 novel potent marker genes (SEPT5, MARN2, PER3, and PISA3) for paclitaxel efficacy in vitro through microarray expression analysis, and then successfully developed the best linear models, which converted the quantified expression data into objective clinical response, in terms of best tumor response (r=0.985, AICS=-5.269) and overall survival (r=0.980, AICS=6.953), using 15 and 13 data sets of gene expression and clinical response, respectively. At present, utility-confirmation analyses using other clinical samples appeared to show that the formulae could accurately predict tumor response. Conclusions: Polygenetic strategies using several known polymorphisms for toxicity and a prediction formula using 4 novel genes for efficacy would be of predictive value for individual response to paclitaxel. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- R. Ikeda
- Hiroshima Cancer Ther Dev Org, Hiroshima, Japan; Hiroshima Univ, Hiroshima, Japan; Iwate Med Univ, Morioka, Japan; Kanagawa Cancer Ctr Hosp, Yokohama, Japan; Kawakita General Hosp, Tokyo, Japan; Showa Univ Toyosu Hosp, Tokyo, Japan
| | - K. Yoshida
- Hiroshima Cancer Ther Dev Org, Hiroshima, Japan; Hiroshima Univ, Hiroshima, Japan; Iwate Med Univ, Morioka, Japan; Kanagawa Cancer Ctr Hosp, Yokohama, Japan; Kawakita General Hosp, Tokyo, Japan; Showa Univ Toyosu Hosp, Tokyo, Japan
| | - A. Takagane
- Hiroshima Cancer Ther Dev Org, Hiroshima, Japan; Hiroshima Univ, Hiroshima, Japan; Iwate Med Univ, Morioka, Japan; Kanagawa Cancer Ctr Hosp, Yokohama, Japan; Kawakita General Hosp, Tokyo, Japan; Showa Univ Toyosu Hosp, Tokyo, Japan
| | - A. Tsuburaya
- Hiroshima Cancer Ther Dev Org, Hiroshima, Japan; Hiroshima Univ, Hiroshima, Japan; Iwate Med Univ, Morioka, Japan; Kanagawa Cancer Ctr Hosp, Yokohama, Japan; Kawakita General Hosp, Tokyo, Japan; Showa Univ Toyosu Hosp, Tokyo, Japan
| | - O. Kobayashi
- Hiroshima Cancer Ther Dev Org, Hiroshima, Japan; Hiroshima Univ, Hiroshima, Japan; Iwate Med Univ, Morioka, Japan; Kanagawa Cancer Ctr Hosp, Yokohama, Japan; Kawakita General Hosp, Tokyo, Japan; Showa Univ Toyosu Hosp, Tokyo, Japan
| | - H. Sunouchi
- Hiroshima Cancer Ther Dev Org, Hiroshima, Japan; Hiroshima Univ, Hiroshima, Japan; Iwate Med Univ, Morioka, Japan; Kanagawa Cancer Ctr Hosp, Yokohama, Japan; Kawakita General Hosp, Tokyo, Japan; Showa Univ Toyosu Hosp, Tokyo, Japan
| | - M. Matsukawa
- Hiroshima Cancer Ther Dev Org, Hiroshima, Japan; Hiroshima Univ, Hiroshima, Japan; Iwate Med Univ, Morioka, Japan; Kanagawa Cancer Ctr Hosp, Yokohama, Japan; Kawakita General Hosp, Tokyo, Japan; Showa Univ Toyosu Hosp, Tokyo, Japan
| | - K. Tanimoto
- Hiroshima Cancer Ther Dev Org, Hiroshima, Japan; Hiroshima Univ, Hiroshima, Japan; Iwate Med Univ, Morioka, Japan; Kanagawa Cancer Ctr Hosp, Yokohama, Japan; Kawakita General Hosp, Tokyo, Japan; Showa Univ Toyosu Hosp, Tokyo, Japan
| | - K. Hiyama
- Hiroshima Cancer Ther Dev Org, Hiroshima, Japan; Hiroshima Univ, Hiroshima, Japan; Iwate Med Univ, Morioka, Japan; Kanagawa Cancer Ctr Hosp, Yokohama, Japan; Kawakita General Hosp, Tokyo, Japan; Showa Univ Toyosu Hosp, Tokyo, Japan
| | - M. Nishiyama
- Hiroshima Cancer Ther Dev Org, Hiroshima, Japan; Hiroshima Univ, Hiroshima, Japan; Iwate Med Univ, Morioka, Japan; Kanagawa Cancer Ctr Hosp, Yokohama, Japan; Kawakita General Hosp, Tokyo, Japan; Showa Univ Toyosu Hosp, Tokyo, Japan
| |
Collapse
|
32
|
Takahashi H, Utoh H, Kitajima S, Isobe M, Suzuki C, Takeuchi M, Ikeda R, Tanaka Y, Yokoyama M, Toi K, Okamura S, Sasao M. Hot Cathode Biasing Experiments in Helical Systems. Fusion Science and Technology 2007. [DOI: 10.13182/fst07-a1287] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- H. Takahashi
- Tohoku University, Department of Quantum Science and Energy Engineering, Sendai, Japan
| | - H. Utoh
- Tohoku University, Department of Quantum Science and Energy Engineering, Sendai, Japan
| | - S. Kitajima
- Tohoku University, Department of Quantum Science and Energy Engineering, Sendai, Japan
| | - M. Isobe
- National Institute for Fusion Science, Toki, Japan
| | - C. Suzuki
- National Institute for Fusion Science, Toki, Japan
| | - M. Takeuchi
- Nagoya University, Department of Energy Engineering and Science, Nagoya, Japan
| | - R. Ikeda
- Nagoya University, Department of Energy Engineering and Science, Nagoya, Japan
| | - Y. Tanaka
- Tohoku University, Department of Quantum Science and Energy Engineering, Sendai, Japan
| | - M. Yokoyama
- National Institute for Fusion Science, Toki, Japan
| | - K. Toi
- National Institute for Fusion Science, Toki, Japan
| | - S. Okamura
- National Institute for Fusion Science, Toki, Japan
| | - M. Sasao
- Tohoku University, Department of Quantum Science and Energy Engineering, Sendai, Japan
| |
Collapse
|
33
|
Kobayashi T, Ohki H, Ikeda R. Molecular Motions in the Novel Plastic Phase of Decamethylferrocene Studied by1H NMR and Thermal Measurements. ACTA ACUST UNITED AC 2006. [DOI: 10.1080/10587259408033784] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- T. Kobayashi
- a Department of Chemistry , University of Tsukuba , Tsukuba , 305 , Japan
| | - H. Ohki
- a Department of Chemistry , University of Tsukuba , Tsukuba , 305 , Japan
| | - R. Ikeda
- a Department of Chemistry , University of Tsukuba , Tsukuba , 305 , Japan
| |
Collapse
|
34
|
Kawamura K, Fujikawa-Yamamoto K, Ozaki M, Iwabuchi K, Nakashima H, Domiki C, Morita N, Inoue M, Tokunaga K, Shiba N, Ikeda R, Suzuki K. Centrosome hyperamplification and chromosomal damage after exposure to radiation. Oncology 2005; 67:460-70. [PMID: 15714003 DOI: 10.1159/000082931] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2003] [Accepted: 04/23/2004] [Indexed: 01/15/2023]
Abstract
OBJECTIVE In order to elucidate the effects of radiation on centrosome hyperamplification (CH), we examined the centrosome duplication cycle in KK47 bladder cancer cells following irradiation. METHODS KK47 cells were irradiated with various doses of radiation and were examined for CH immunostaining for gamma-tubulin. RESULTS Nearly all control cells contained one or two centrosomes, and mitotic cells displayed typical bipolar spindles. The centrosome replication cycle is well regulated in KK47. Twenty-four hours after 5-Gy irradiation, approximately 80% of irradiated cells were arrested in G2 phase, and at 48 h after irradiation, 56.9% of cells contained more than two centrosomes. Laser scanning cytometry performed 48 h after irradiation showed the following two pathways: (1) unequal distribution of chromosomes to daughter cells, or (2) failure to undergo cytokinesis, resulting in polyploidy. With mitotic collection, M-phase cells with CH could be divided into G1 cells with micronuclei and polyploidal cells. Fluorescence in situ hybridization analysis showed clear signs of chromosomal instability (CIN) at 48 h after irradiation. The present study had two major findings: (1) continual duplication of centrosomes occurred in the cell cycle-arrested cells upon irradiation, leading to centrosome amplification; (2) cytokinesis failure was due to aberrant mitotic spindle formation caused by the presence of amplified centrosomes. Abnormal mitosis with amplified centrosomes was detected in the accumulating G2/M population after irradiation, showing that this amplification of centrosomes was not caused by failure to undergo cytokinesis, but rather that abnormal mitosis resulting from amplification of centrosomes leads to cytokinesis block. CONCLUSION These results suggest that CH is a critical event leading to CIN following exposure to radiation.
Collapse
Affiliation(s)
- K Kawamura
- Department of Urology, Kanazawa Medical University, Daigaku Uchinada, Ishikawa, Japan.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Ikeda R, Kato F. Early and transient increase in spontaneous synaptic inputs to the rat facial motoneurons after axotomy in isolated brainstem slices of rats. Neuroscience 2005; 134:889-99. [PMID: 15994018 DOI: 10.1016/j.neuroscience.2005.05.002] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2005] [Revised: 05/10/2005] [Accepted: 05/11/2005] [Indexed: 02/05/2023]
Abstract
Section of motor nerve fibers (axotomy) elicits a variety of morphofunctional responses in the motoneurons in the motor nuclei. Later than the fifth post-operational day after section of the facial nerve, synapse elimination occurs in the facial motoneuron pool, leading to gradual abolishment of synaptic input-driven activities of the axotomized motoneurons. However, it remains unknown how the amount of synaptic input changes during this period between the axotomy and the synaptic elimination. Here we examined a hypothesis that axotomy of the motoneurons itself modifies the synaptic inputs to the motoneurons. One day after axotomy, the postsynaptic currents, mostly mediated by non-N-methyl-D-aspartic acid (non-NMDA) receptors, recorded from the axotomized facial motoneurons in the acute slice preparations of the rats were of higher frequency and larger amplitude than those in the intact motoneurons. This difference was not observed after the third post-operational day and appeared earlier than the changes in the electrophysiological properties and increase in the number of dead neurons in the axotomized motor nucleus. The larger postsynaptic current frequency of the axotomized motoneurons was observed both in the absence and in the presence of tetrodotoxin citrate, suggesting that increased excitability and facilitated release underlie the postsynaptic current frequency increase. These results suggest that synaptic re-organization occurs in the synapses of motoneurons at an early stage following axotomy.
Collapse
Affiliation(s)
- R Ikeda
- Laboratory of Neurophysiology, Department of Neuroscience, Jikei University School of Medicine, 3-25-8 Nishi-shimbashi, Minato-ku, Tokyo 105-8461, Japan
| | | |
Collapse
|
36
|
Higashi K, Ueda Y, Ikeda R, Kodama Y, Guo J, Matsunari I, Oguchi M, Tonami H, Katsuda S, Yamamoto I. P-glycoprotein expression is associated with FDG uptake and cell differentiation in patients with untreated lung cancer. Nucl Med Commun 2004; 25:19-27. [PMID: 15061261 DOI: 10.1097/00006231-200401000-00004] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
In vitro studies demonstrated that the accumulation of 2-deoxy-D-glucose was reduced in multidrug resistant cell lines. In animal study, it has been suggested that 2-[18F]fluoro-2-deoxy-D-glucose (FDG) may be a marker for multidrug resistance (MDR). The aim of this clinical study was to compare MDR characteristics by immunohistochemical assay with FDG uptake and investigate whether FDG is a marker for MDR in patients with untreated lung cancer. Forty-seven patients with 49 untreated lung cancers, who had undergone both preoperative FDG PET imaging and thoracotomy, were enrolled in this study. Before surgery, FDG PET was performed 40 min after injection, and standardized uptake values (SUVs) were obtained. Patients were classified into low-SUV (< or = 5) and high-SUV (> 5) groups. After surgery, the expression of P-glycoprotein (Pgp) was investigated by immunohistochemistry, and the lung cancer FDG uptake was analysed for possible association with Pgp expression. The strong intensity of Pgp immunoreactivity was seen only in the low-SUV group. The percentage of the Pgp positive area was significantly lower in the high-SUV group (21.7 +/- 13.4%) than in the low-SUV group (44.1 +/- 29.7%) (P = 0.015). In the high-SUV group, the percentage of Pgp positive area did not exceed 50%. In lung adenocarcinoma, the intensity of Pgp immunoreactivity and the percentage of Pgp positive area increased with degree of cell differentiation, while FDG uptake decreased with degree of cell differentiation. Bronchioloalveolar carcinoma, in particular, showed overexpression of Pgp and modest uptake of FDG. In conclusion, Pgp expression was found to be inversely related to FDG uptake in untreated lung cancer. Pgp expression correlated with the degree of cell differentiation in adenocarcinomas, whilst FDG uptake was inversely related to cell differentiation. FDG may be an in vivo marker for MDR in patients with untreated lung cancer.
Collapse
MESH Headings
- ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism
- Adenocarcinoma, Bronchiolo-Alveolar/diagnostic imaging
- Adenocarcinoma, Bronchiolo-Alveolar/metabolism
- Adenocarcinoma, Bronchiolo-Alveolar/pathology
- Adenocarcinoma, Bronchiolo-Alveolar/surgery
- Aged
- Aged, 80 and over
- Biomarkers, Tumor/metabolism
- Cell Division
- Drug Resistance, Multiple
- Female
- Fluorodeoxyglucose F18/pharmacokinetics
- Gene Expression Regulation, Neoplastic
- Humans
- Lung Neoplasms/diagnostic imaging
- Lung Neoplasms/metabolism
- Lung Neoplasms/pathology
- Lung Neoplasms/surgery
- Male
- Middle Aged
- Radionuclide Imaging
- Radiopharmaceuticals/pharmacokinetics
- Reproducibility of Results
- Sensitivity and Specificity
- Statistics as Topic
Collapse
Affiliation(s)
- K Higashi
- Department of Radiology, Kanazawa Medical University, Uchinada, Ishikawa, Japan.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Shibayama Y, Ikeda R, Motoya T, Yamada K. St. John's Wort (Hypericum perforatum) induces overexpression of multidrug resistance protein 2 (MRP2) in rats: a 30-day ingestion study. Food Chem Toxicol 2004; 42:995-1002. [PMID: 15110109 DOI: 10.1016/j.fct.2004.02.012] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2002] [Accepted: 02/16/2004] [Indexed: 11/27/2022]
Abstract
St. John's Wort (Hypericum perforatum, SJW) has been used as a herbal medicine for the treatment of depression in oral doses of 900-1050 mg/day in humans. However, the ingestion of SJW was reported to cause interactions with drugs. In the present study, we examined the effects of SJW treatment on the induction of drug transporters and enzymes in rats. An immunoblot analysis was performed to quantify the expression of the transporters and enzymes. SJW was given at a dose of 400 mg/kg/day, since it was reported that 400 mg/kg/day is antidepressant effective dose in rats. When SJW was administered for 10 days, the amounts of multidrug resistance protein 2 (MRP2), glutathione S-transferase-P (GST-P) and cytochrome P450 1A2 (CYP1A2) in the liver were increased to 304%, 252% and 357% of controls, respectively, although the amounts of P-glycoprotein and multidrug resistance protein 1 were not changed. Under the same conditions, an increase of MRP2 in the kidney was not observed. The increase in the levels of each protein was maximal at 10 days after SJW treatment and lasted for at least 30 consecutive days. These results suggest that SJW induces hepatic MRP2, GST-P and CYP1A2 overexpressions, and thus, it could affect drug metabolism, conjugation and disposition.
Collapse
Affiliation(s)
- Y Shibayama
- Department of Clinical Pharmacy and Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan
| | | | | | | |
Collapse
|
38
|
Kawamura K, Moriyama M, Shiba N, Ozaki M, Tanaka T, Nojima T, Fujikawa-Yamamoto K, Ikeda R, Suzuki K. Centrosome hyperamplification and chromosomal instability in bladder cancer. Eur Urol 2003; 43:505-15. [PMID: 12705995 DOI: 10.1016/s0302-2838(03)00056-3] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/07/2022]
Abstract
OBJECTIVE Chromosomal instability (CIN) is a common feature of malignant tumors. Centrosome hyperamplification (CH) occurs frequently in human cancers, and may be a contributing factor in CIN. In this study, we investigated the relationship between CH and CIN in bladder cancer. METHODS Clinical samples obtained by transurethral resection from 22 patients with bladder cancer were examined (histological grade G1, 5 cases; G2, 6 cases; G3, 11 cases). CH was evaluated by immunohistochemistry using anti-pericentrin antibody. CIN was evaluated by fluorescence in situ hybridization (FISH). FISH probes for pericentromeric regions of chromosomes 3, 7, and 17 were hybridized to touch preparations of nuclei from frozen tissues. We also analyzed the centrosome replication cycle of bladder cancer by laser scanning cytometry (LSC). RESULTS Of the 22 cases examined, 18 (81.8%) had centrosome hyperamplification: CH 0, 4 cases (18.1%); CH I, 5 cases (22.7%); CH II, 5 cases (22.7%); CH III, 8 cases (36.4%). The grade of CH was directly proportional to the histological grade (p=0.03, chi(2) test). LSC analysis showed that the centrosome replication cycle was well regulated in pathologically low-grade bladder cancer, which did not have chromosomal instability. In contrast, we found marked variability of centrosomes in pathologically high-grade bladder cancer, which had chromosomal instability. CH and CIN were both detected in pathologically high-grade tumors. The grade of CH was directly proportional to the CIN grade (p=0.0079, chi(2) test). CONCLUSION The results of the present study suggest that CH may be involved in CIN in bladder cancer.
Collapse
Affiliation(s)
- K Kawamura
- Department of Urology, Kanazawa Medical University, 1-1 Daigaku Uchinada, 920-0293, Ishikawa, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Sugita T, Ikeda R, Shinoda T. Diversity among strains of Cryptococcus neoformans var. gattii as revealed by a sequence analysis of multiple genes and a chemotype analysis of capsular polysaccharide. Microbiol Immunol 2002; 45:757-68. [PMID: 11791669 DOI: 10.1111/j.1348-0421.2001.tb01312.x] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
We demonstrated the diversity of Cryptococcus neoformans var. gattii strains by a sequence analysis of multiple genes: (i) the intergenic spacer (IGS) 1 and 2 regions of the rRNA gene; (ii) the internal transcribed spacer (ITS) region, including 5.8S of the rRNA gene; (iii) TOP1 (topoisomerase); and (iv) CAP59. In these studies, we compared C. neoformans var. gattii with varieties grubii, and neoformans of C. neoformans. Phylogenetic analysis indicated that both C. neoformans var. grubii and C neoformans var. neoformans are monophyletic, but C. neoformans var. gattii showed polyphyletic. C. neoformans var. gattii can be divided into three phylogenetic groups, I, II, and III, with high bootstrap support. Phylogenetic group I contains serotype B and C strains, and groups II and III include serotype B strains. Because the serotype B strains of C. neoformans var. gattii exhibited more genetic divergence, the serological characteristics and chemotypes of their capsular polysaccharide were further investigated. No remarkable difference among the serotype B strains was found in the reactivities to factor serum 5, which is specific for serotype B. The NMR spectra of the capsular polysaccharide from serotype B strains could be divided into three characteristic patterns, but the chemical shifts were very similar. These results suggested that the serotype B strain of C. neoformans var. gattii has more genetic diversity than the serotype C strain of C. neoformans var. gattii or the varieties grubii and neoformans of C. neoformans, but there was no correlation between genotype and chemotype.
Collapse
Affiliation(s)
- T Sugita
- Department of Microbiology, Meiji Pharmaceutical University, Noshio, Kiyose, Tokyo, Japan.
| | | | | |
Collapse
|
40
|
Sugita T, Takashima M, Ikeda R, Nakase T, Shinoda T. Intraspecies diversity of Cryptococcus albidus isolated from humans as revealed by sequences of the internal transcribed spacer regions. Microbiol Immunol 2002; 45:291-7. [PMID: 11386419 DOI: 10.1111/j.1348-0421.2001.tb02621.x] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The basidiomycetous yeast, Cryptococcus albidus, shows intraspecies diversity, but it is rarely isolated from immunocompromised patients. Nineteen strains of C. albidus, including nine clinical isolates, were re-classified by sequences of their rRNA internal transcribed spacer (ITS) regions. The nine clinical isolates were genetically diverse and included both C. albidus and C. diffluens. One clinical isolate, recovered from the blood of an AIDS patient, represented a new species. Only small differences were found in the biochemical and serological characteristics of C. albidus and C. diffluens. All isolates were sensitive to amphotericin B, but several isolates were resistant to fluconazole and itraconazole. C. albidus heterogeneity should be taken into consideration when identifying clinical isolates.
Collapse
Affiliation(s)
- T Sugita
- Department of Microbiology, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan.
| | | | | | | | | |
Collapse
|
41
|
Krockenberger MB, Canfield PJ, Kozel TR, Shinoda T, Ikeda R, Wigney DI, Martin P, Barnes K, Malik R. An immunohistochemical method that differentiates Cryptococcus neoformans varieties and serotypes in formalin-fixed paraffin-embedded tissues. Med Mycol 2001. [DOI: 10.1080/714031068] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
42
|
Ikeda R, Aiyama S, Tsujimura T, Okamoto K. Developmental changes in the fine structure and histochemical properties of mucous cells in the parotid gland of the infant Japanese macaque. Arch Histol Cytol 2001; 64:545-53. [PMID: 11838714 DOI: 10.1679/aohc.64.545] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Mucous cells have been known to occur in the terminal portions of the parotid gland in a few species of mammals during a limited period of their development. The aim of this study was to examine the occurrence and features of mucous cells in the parotid gland of the infant Japanese macaque. Light microscopy revealed that mucous cells in the macaque parotid gland were present in the terminal clusters and acini at postnatal day 15, were less prevalent at day 30, and continued to decrease in number over 3 months. Mucous cells were no longer recognized in the parotid gland in 6-month-old macaques. Electron microscopy showed that the mucous cells contained electron-lucent secretory granules and bipartite or tripartite secretory granules. By 3 months of age, there was a scarcity of mucous cells and a concomitant increase in transitional cells. These transitional cells were intermediate in structure between mucous and serous cells, and contained three types of granules: electron-lucent, bipartite or tripartite, and electron-dense. None of the cells showed apoptotic figures. Lectin histochemistry indicated that the mucous cells in the early postnatal period had sugar residues identical in nature to those seen in the granules from mature serous cells in the glands of 3-month-old macaques. Immunohistochemistry using an antibody against human alpha-amylase showed a weakly positive reactivity in the secretory granules of the mucous cells, starting from day 15. In the transitional cells, the electron-dense granules showed a stronger immunoreactivity than either the electron-lucent granules or the heterogeneously structured granules. These results suggest that the secretory granules of mucous cells have characteristics in common with those of serous cells, and that during the transitional period the mucous granules change from the initial electron-lucent to hetorogenous forms, finally becoming the electron-dense granules. The mucous cells in the parotid gland of the juvenile Japanese macaque are therefore suggested to be converted into serous cells.
Collapse
Affiliation(s)
- R Ikeda
- Department of Histology, The Nippon Dental University School of Dentistry at Tokyo, Japan.
| | | | | | | |
Collapse
|
43
|
Mori S, Takao S, Ikeda R, Noma H, Mataki Y, Wang X, Akiyama S, Aiko T. Role of thymidine phosphorylase in Fas-induced apoptosis. Hum Cell 2001; 14:323-30. [PMID: 11925935] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
Abstract
Thymidine phosphorylase (TP) has chemotactic and angiogenic activity in vitro, and it promotes tumor growth and inhibits apoptosis in vivo. It plays a key role in the invasiveness and metastasis of TP-expressing solid tumors. KB/TP cells transfected with a TP cDNA have been shown to be resistant to hypoxia-induced apoptosis, suggesting that TP has effects on tumor growth and cell death independent of its effects on angiogenesis. However, the mechanisms of cell death inhibition by TP are unknown. In the present study, we demonstrate that caspase-8 is cleaved in control transfectant KB cells early on during Fas-induced apoptosis. Caspase-8 activation leads to the loss of mitochondrial membrane potential, followed by the release of cytochrome c, the activation of caspase-3, and apoptosis. In contrast, Fas-induced caspase-8 cleavage is inhibited in KB/TP cells, which lead to inhibition of the downstream apoptotic cascade and inhibition of apoptosis. These findings indicate that TP plays an important role in intracellular apoptotic signal transduction in the Fas-induced apoptotic pathway. Therefore, inhibition of TP may suppress the progression of TP-overexpressing solid tumors by inducing apoptosis.
Collapse
Affiliation(s)
- S Mori
- First Department of Surgery, Kagoshima University School of Medicine, Kagoshima, Japan
| | | | | | | | | | | | | | | |
Collapse
|
44
|
Krockenberger MB, Canfield PJ, Kozel TR, Shinoda T, Ikeda R, Wigney DI, Martin P, Barnes K, Malik R. An immunohistochemical method that differentiates Cryptococcus neoformans varieties and serotypes in formalin-fixed paraffin-embedded tissues. Med Mycol 2001; 39:523-33. [PMID: 11798058 DOI: 10.1080/mmy.39.6.523.533] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
Abstract
An immunohistochemical method for determining the variety of Cryptococcus neoformans in formalin-fixed paraffin-embedded tissues was developed using mAbs 471, 302 and CRND8. The method was validated primarily using veterinary patients for which both formalin-fixed lesions and a cultured isolate were available. L-Canavanine glycine bromothymol blue (CGB) agar and the 'Crypto-Check' kit were used to determine the variety and serotype, respectively, of cultured isolates. Immunohistochemistry accurately predicted the C. neoformans variety in all tissue specimens. The CGB agar method of determining C. neoformans variety gave the same result as immunohistochemistry for 30/31 specimens. For the single discordant isolate, the serotype, random amplification of polymorphic DNA profile, microscopic and colony morphology all supported the immunohistochemical staining pattern in suggesting C. neoformans var. gattii; however, the CGB agar result was at variance. Of the C. neoformans var. neoformans cases, immunohistochemistry was congruent with variety for 13/13 cases and with serotyping for 10/13 cases. The three discordant cases were classified as having some serotype D reactivity by immunohistochemistry, but were considered to be serotype A using the Crypto-Check kit. This new method should prove a valuable epidemiological tool in studies of cryptococcosis, especially in the veterinary setting where archival tissue specimens may exist but corresponding mycological data is typically absent. The versatility of this method will expand in the future as other monoclonal antibodies with different specificities are developed.
Collapse
Affiliation(s)
- M B Krockenberger
- Faculty of Veterinary Science, The University of Sydney, New South Wales, Australia.
| | | | | | | | | | | | | | | | | |
Collapse
|
45
|
Abstract
A new concept for the design and laccase-catalyzed preparation of "artificial urushi" from new urushiol analogues is described. The curing proceeded under mild reaction conditions to produce the very hard cross-linked film (artificial urushi) with a high gloss surface. A new cross-linkable polyphenol was synthesized by oxidative polymerization of cardanol, a phenol derivative from cashew-nut-shell liquid, by enzyme-related catalysts. The polyphenol was readily cured to produce the film (also artificial urushi) showing excellent dynamic viscoelasticity.
Collapse
Affiliation(s)
- S Kobayashi
- Department of Materials Chemistry, Graduate School of Engineering, Kyoto University, Japan.
| | | | | |
Collapse
|
46
|
Sugita T, Nakajima M, Ikeda R, Niki Y, Matsushima T, Shinoda T. A nested PCR assay to detect DNA in sera for the diagnosis of deep-seated trichosporonosis. Microbiol Immunol 2001; 45:143-8. [PMID: 11293480 DOI: 10.1111/j.1348-0421.2001.tb01282.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
Deep-seated trichosporonosis caused by Trichosporon asahii has a high mortality rate and a very poor prognosis. New species-specific oligonucleotide primers for T. asahii were developed from a sequence analysis of rRNA genes that included the internal transcribed spacer regions. A nested PCR assay with specific primers was used to examine 11 serum samples from 7 patients, who were diagnosed with deep-seated trichosporonosis histologically at autopsy. In addition, Trichosporon cell wall polysaccharide (PS) was detected by a latex agglutination (LA) test. Of 11 samples, seven had a positive LA test, and T. asahii DNA was also detected with the nested PCR assay. Of the four samples in which PS antigen was not detected, the nested PCR of two samples was positive. Our new nested PCR assay may be used as an adjunct to conventional methods for diagnosing T. asahii infection.
Collapse
Affiliation(s)
- T Sugita
- Department of Microbiology, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan.
| | | | | | | | | | | |
Collapse
|
47
|
Ichikawa T, Nishikawa A, Ikeda R, Shinoda T. Structural studies of a cell wall polysaccharide of Trichosporon asahii containing antigen II. Eur J Biochem 2001; 268:5098-106. [PMID: 11589701 DOI: 10.1046/j.0014-2956.2001.02438.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The structure of a cell-wall polysaccharide containing antigen II from Trichosporon asahii was investigated. A purified glucuronoxylomannan (GXM) antigen was found to contain O-acetyl groups that contribute to the serological reactivity. The structure of GXM was analyzed by partial acid hydrolysis, methylation analysis, controlled Smith degradation, NMR studies, and fluorophore-assisted carbohydrate electrophoresis. GXM has an alpha-(1-->3)-D-mannan backbone with a beta-D-glucopyranosyluronic acid residue bound to O-2 of a mannopyranosyl residue and the same number of beta-D-xylopyranosyl residues as mannose. Side chains of beta-D-xylopyranosyl-D-xylopyranose, forming a nonreducing terminus, and beta-D-xylopyranosyl residues were attached to O-2, O-4, and O-6 of the mannose residues.
Collapse
Affiliation(s)
- T Ichikawa
- Department of Microbiology, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588, Japan.
| | | | | | | |
Collapse
|
48
|
Abstract
BACKGROUND The aim of this study was to characterize the lymph vessels in different parts of the gastrointestinal tract and also to evaluate morphometric changes in these vessels during cirrhotic portal hypertension. METHODS Sixteen patients with cirrhotic portal hypertension and 18 control subjects without portal hypertension were enrolled in the study. Tissue specimens were collected at autopsy or surgery, and were stained enzyme histochemically, using 5'-nucleotidase and alkaline phosphatase to distinguish lymph vessels and blood vessels, respectively. The numbers of vessels and their luminal areas were estimated using computer graphics software (National Institutes of Health [NIH] image program). RESULTS The numbers and luminal areas of the lymph vessels varied considerably among the different organs of the gastrointestinal tract, both in controls and in the patients with cirrhotic portal hypertension. There was no significant difference in the numbers of lymph vessels between controls and patients with cirrhotic portal hypertension. However, the luminal area of the lymph vessels in the esophagus and stomach was significantly greater in the patients with cirrhotic portal hypertension than in the controls. These differences in lymph vessels were not seen in the small intestine and colon. CONCLUSIONS These data indicate that dilatation of lymph vessels may be related to the absorption of excess interstitial fluid, resulting from congestion, in cirrhotic portal hypertension.
Collapse
Affiliation(s)
- R Ikeda
- Third Department of Internal Medicine, Ehime University School of Medicine, Onsen-gun, Japan
| | | | | | | | | |
Collapse
|
49
|
Makiura R, Nagasawa I, Kimura N, Ishimaru S, Kitagawa H, Ikeda R. An unusual six-co-ordinate platinum(II) complex containing a neutral I2 ligand. Chem Commun (Camb) 2001:1642-3. [PMID: 12240422 DOI: 10.1039/b103648n] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The present paper deals with a rare platinum(II) complex containing the kappa-I2 ligand, which is an unusual example of a six-co-ordinated octahedral platinum(II) complex.
Collapse
Affiliation(s)
- R Makiura
- Department of Chemistry, University of Tsukuba, Tennodai 1-1-1, Tsukuba, Ibaraki 305-8571, Japan
| | | | | | | | | | | |
Collapse
|
50
|
Shiono Y, Ikeda R, Hayashi H, Wakusawa S, Sanae F, Takikawa T, Imaizumi Y, Yano M, Yoshioka K, Kawanaka M, Yamada G. C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan. Intern Med 2001; 40:852-6. [PMID: 11579943 DOI: 10.2169/internalmedicine.40.852] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
OBJECTIVE The gene responsible for hereditary hemochromatosis close to the human leukocyte antigen A locus was previously identified and designated as HFE. This study was performed to evaluate the clinical significance of two mutations, C282Y and H63D of HFE, in Japanese patients with hepatic iron overload. PATIENTS AND METHODS We examined C282Y and H63D in 11 patients with primary hemochromatosis, 94 patients with chronic hepatitis C, 54 patients with miscellaneous liver diseases, and 151 healthy volunteers. The HFE gene region of DNA samples extracted from peripheral leukocytes was amplified by polymerase chain reaction. Restriction enzyme analysis was performed using SnaBI for C282Y and BclI for H63D. Direct sequence analysis was then performed when products suggested the presence of a mutation. RESULTS All the subjects studied were free from C282Y. None of the patients with hemochromatosis had H63D. One patient with chronic hepatitis C was homozygous, and 4 patients were heterozygous for H63D. Two patients with alcoholic liver disease were heterozygous for H63D. The prevalence of chromosomes with H63D was 6/188 (3.2%) in patients with chronic hepatitis C, 2/108 (1.9%) in patients with miscellaneous liver diseases, and 8/302 (2.6%) in healthy volunteers. These differences were not significant. CONCLUSION Our results suggested that neither C282Y nor H63D in HFE affect Japanese patients with hemochromatosis or chronic hepatitis C.
Collapse
Affiliation(s)
- Y Shiono
- Department of Medicine, Faculty of Pharmaceutical Sciences, Hokuriku University, Kanazawa, Ishikawa
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|